Open Access111 In-pentetreotide SPECT CT Value in Follow-up of Patients with Neuro-Endocrine Tumors
Author(s) -
Badriya Al-Suqri
Publication year - 2014
Publication title -
oman medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 31
eISSN - 2070-5204
pISSN - 1999-768X
DOI - 10.5001/omj.2014.95
Subject(s) - medicine , pelvis , abdomen , radiology , thorax (insect anatomy) , single photon emission computed tomography , somatostatin receptor , computed tomography , emission computed tomography , nuclear medicine , neuroendocrine tumors , tomography , positron emission tomography , pathology , somatostatin , anatomy
Carcinoid tumors are relatively rare and can occur in the thorax, abdomen, or pelvis. Functional imaging in the form of Indium-111 pentetreotide scanning is widely used for identification of these tumors and it exploits the fact that the vast majority of these tumors express somatostatin receptors on their cell membrane. In this report, we present a case of a 76-year-old man who was diagnosed with peritoneal carcinomatosis. The findings of the initial imaging made by planar and single photon emission computed tomography were misleading and the actual diagnosis was only made by single photon emission computed tomography/computed tomography.